A Diagnostic Ceiling for Exome Sequencing in Cerebellar Ataxia and Related Neurological Disorders (2006)

Abstract

CONFLICT OF INTERESTS JRL serves on the scientific advisory board for Baylor Genetics, has stock ownership in 23andMe, is a paid consultant for Regeneron Pharmaceuticals, and is a coinventor on multiple US and European patents related to molecular diagnostics for inherited neuropathies, eye diseases, and bacterial genomic fingerprinting. All other authors declare that there is no conflict of interest. DATA AVAILABILITY STATEMENTThe data that support the findings of this study are not publicly available due to privacy restrictions but may be made available in whole or in part from the corresponding author upon reasonable request. SUPPORTING INFORMATIONAdditional supporting information may be found online in the Supporting Information section.